STONY BROOK, NY --(Marketwired - April 21, 2015) - Applied DNA Sciences, Inc. (
This patent broadens the claims of previously granted US Patent No. 8,372,648, and allows the patent to cover a broader range of optical marker formulation composition.
- This patent allows more flexibility in optical marker formulation and expands the range of possible optical markers that we can produce.
- It is now possible to generate optical markers of various properties and, in conjunction with covalently linked DNA, forms a range of new markers with both instant read and forensic qualities.
Dr. Benjamin Liang, Chief Scientific Officer, APDN, stated: "This patent demonstrates our continuous effort in developing new line of field-readable forensic markers. When coupled with our in-field multimode readers, on-site authentication has become a reality."
Dr. James Hayward, President and CEO of Applied DNA Sciences, stated: "Whether used in anti-counterfeit packaging, law enforcement or the protection of home assets, these markers enable the on-site recognition of complex spectra for our DNA-associated covert marks. We are steadily adding to our authentication toolbox."
About Applied DNA Sciences We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature ® DNA describes the platform ingredient that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of uncopyable products such as DNAnet ® , our anti-theft product, SigNature ® T, targeted toward textiles, and digitalDNA ® , providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators.
Applied DNA Sciences common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.
Forward Looking Statements The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 15, 2014, as amended on March 6, 2015, and our subsequent quarterly report on Form 10-Q filed on February 9, 2015 which are available at www.sec.gov . APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
investor contact: Debbie Bailey 631-240-8817 Email contact media contact: Enrique Briz Dian Griesel Int'l. 212-825-3210 Email contact web: Email contact twitter: @APDN
